Tahara M, Kiyota N, Imai H, Takahashi S, et al. A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan. Thyroid 2024 Feb 12. doi: 10.1089/thy.2023.0547.
PMID: 38343359